Roger Echols Net Worth & Insider Trades

Roger Echols - Chief Medical Officer, Replidyne Inc

As of November 1, 2007

What is Roger Echols's Net Worth?

The current estimated net worth of Replidyne Inc's Chief Medical Officer, Roger Echols, is estimated to be about $642.83K . Roger Echols owns about 46,957 units of Replidyne Inc common stock. In the last 9 months at Replidyne Inc, Roger Echols has sold an estimated value of $306.56K worth.

What is Roger Echols's Past Insider Trading?

Roger Echols's largest sale order was 10,000 units , worth over $60K on March 5, 2007. In total, Roger Echols has made about 9 transactions over 9 months of their time at Replidyne Inc. Roger Echols usually trades in March and August, with the busiest year in 2007. The most recent transaction was a sale order of 5,000 units , worth over $30.3K on November 1, 2007.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Roger Echols

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Roger Echols's' Mailing Address?

  • Mailing address is C/o Replidyne, Inc. 1450 Infinite Drive Louisville CO 80027 CO

What are Replidyne Inc's Past Insider Trades?

Replidyne Inc's most recent insider trade came on December 16, 2008 by Daniel Mitchell who bought 10,000 units worth $7.47K . In the last 2 years, insiders at Replidyne Inc have sold an estimated value of $624.92K and bought an estimated value of $231.5K worth of shares. Insider trading is most common in March, with the busiest year in 2007. The most active traders at the company are Daniel Mitchell, Director,  Roger Echols, Chief Medical Officer,  and Donald Morrissey Jr, Sr. VP .

REPLIDYNE INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...